Changes in Beneficial Ownership · 4
Larimar Therapeutics, Inc.
LRMRNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-07-06
- Issuer
- Larimar Therapeutics, Inc.
- Issuer CIK
- 0001374690
- Trading symbol
- LRMR
Reporting owner 1
- Name
- Hamilton Thomas Edward
- Reporting owner CIK
- 0001769848
- Relationship
- Director
- Address
- C/O LARIMAR THERAPEUTICS, INC., THREE BALA PLAZA EAST, SUITE 506, BALA CYNWYD, PA, 19004
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-07-06 | P · Form 4 | 50,000 | A | 3.3378[F1] | 714,798 | D |
Table key
- P · Form 4
- Purchase on the market or privately
- A
- Acquired
- D
- Direct
Non-derivative holdings
| Security | Amount owned | Ownership | Nature of ownership |
|---|---|---|---|
| Common Stock | 159,433 | I | Post Edison, LLC |
Table key
- I
- Indirect
Footnotes
- F1
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.↩ 1
Signature 1
- Signed
- /s/ Jennifer Johansson, Attorney-in-fact
- Date
- 2026-07-08
Company context
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar’s lead compound, nomlabofusp, is being developed as a potential treatment for Friedreich's ataxia. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.
Current securities
Recent company filings
- 4 filingNov 12, 2026
- Results of Operations and Financial Condition · Other EventsNov 9, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 29, 2026
- 10-Q filingAug 4, 2026
- Results of Operations and Financial Condition · Other EventsAug 4, 2026